TickerFactsScreenerDevelopers

International Stem Cell CORP (ISCO) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2010: -$6.95M2011: -$6.96M2012: -$6.69M2013: -$5.64M2017: -$2.14M2018: -$1.08M2019: -$1.40M2020: -$341.0K2021: -$1.30M2022: $332.0K2023: $929.0K2024: $13.0K2025: $8.0K$8.0K
2010Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$8.0K-38.5%
2024$13.0K-98.6%
2023$929.0K+179.8%
2022$332.0K+125.6%
2021-$1.30M-280.4%
2020-$341.0K+75.6%
2019-$1.40M-29.1%
2018-$1.08M+49.5%
2017-$2.14M—
2013-$5.64M+15.7%
2012-$6.69M+3.9%
2011-$6.96M-0.2%
2010-$6.95M—